ID   KAD4_HUMAN              Reviewed;         223 AA.
AC   P27144; B2R927; D3DQ62; Q6IBH4; Q6NXQ5; Q8IUU9;
DT   01-AUG-1992, integrated into UniProtKB/Swiss-Prot.
DT   01-AUG-1992, sequence version 1.
DT   12-APR-2017, entry version 173.
DE   RecName: Full=Adenylate kinase 4, mitochondrial {ECO:0000255|HAMAP-Rule:MF_03170};
DE            Short=AK 4 {ECO:0000255|HAMAP-Rule:MF_03170};
DE            EC=2.7.4.10 {ECO:0000255|HAMAP-Rule:MF_03170};
DE            EC=2.7.4.6 {ECO:0000255|HAMAP-Rule:MF_03170};
DE   AltName: Full=Adenylate kinase 3-like {ECO:0000255|HAMAP-Rule:MF_03170};
DE   AltName: Full=GTP:AMP phosphotransferase AK4 {ECO:0000255|HAMAP-Rule:MF_03170};
GN   Name=AK4 {ECO:0000255|HAMAP-Rule:MF_03170};
GN   Synonyms=AK3, AK3L1 {ECO:0000255|HAMAP-Rule:MF_03170};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=1639383; DOI=10.1016/0888-7543(92)90122-9;
RA   Xu G., O'Connell P., Stevens J., White R.;
RT   "Characterization of human adenylate kinase 3 (AK3) cDNA and mapping
RT   of the AK3 pseudogene to an intron of the NF1 gene.";
RL   Genomics 13:537-542(1992).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Testis;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain, Colon, and Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   TISSUE SPECIFICITY, AND SUBCELLULAR LOCATION.
RX   PubMed=11485571; DOI=10.1042/0264-6021:3580225;
RA   Noma T., Fujisawa K., Yamashiro Y., Shinohara M., Nakazawa A.,
RA   Gondo T., Ishihara T., Yoshinobu K.;
RT   "Structure and expression of human mitochondrial adenylate kinase
RT   targeted to the mitochondrial matrix.";
RL   Biochem. J. 358:225-232(2001).
RN   [8]
RP   FUNCTION, CATALYTIC ACTIVITY, SUBCELLULAR LOCATION, BIOPHYSICOCHEMICAL
RP   PROPERTIES, AND MUTAGENESIS OF LYS-4 AND ARG-7.
RX   PubMed=19766732; DOI=10.1016/j.biocel.2009.09.007;
RA   Panayiotou C., Solaroli N., Johansson M., Karlsson A.;
RT   "Evidence of an intact N-terminal translocation sequence of human
RT   mitochondrial adenylate kinase 4.";
RL   Int. J. Biochem. Cell Biol. 42:62-69(2010).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [10]
RP   FUNCTION, AND CATALYTIC ACTIVITY.
RX   PubMed=23416111; DOI=10.1016/j.biocel.2013.02.004;
RA   Amiri M., Conserva F., Panayiotou C., Karlsson A., Solaroli N.;
RT   "The human adenylate kinase 9 is a nucleoside mono- and diphosphate
RT   kinase.";
RL   Int. J. Biochem. Cell Biol. 45:925-931(2013).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [13]
RP   X-RAY CRYSTALLOGRAPHY (2.05 ANGSTROMS) IN COMPLEX WITH DIGUANOSINE
RP   PENTAPHOSPHATE.
RG   Structural genomics consortium (SGC);
RT   "Crystal structure of human adenylate kinase 4 (AK4) in complex with
RT   diguanosine pentaphosphate.";
RL   Submitted (DEC-2005) to the PDB data bank.
RN   [14]
RP   X-RAY CRYSTALLOGRAPHY (2.3 ANGSTROMS), AND FUNCTION.
RX   PubMed=19073142; DOI=10.1016/j.bbrc.2008.12.012;
RA   Liu R., Xu H., Wei Z., Wang Y., Lin Y., Gong W.;
RT   "Crystal structure of human adenylate kinase 4 (L171P) suggests the
RT   role of hinge region in protein domain motion.";
RL   Biochem. Biophys. Res. Commun. 379:92-97(2009).
CC   -!- FUNCTION: Involved in maintaining the homeostasis of cellular
CC       nucleotides by catalyzing the interconversion of nucleoside
CC       phosphates. Efficiently phosphorylates AMP and dAMP using ATP as
CC       phosphate donor, but phosphorylates only AMP when using GTP as
CC       phosphate donor. Also displays broad nucleoside diphosphate kinase
CC       activity. {ECO:0000255|HAMAP-Rule:MF_03170,
CC       ECO:0000269|PubMed:19073142, ECO:0000269|PubMed:19766732,
CC       ECO:0000269|PubMed:23416111}.
CC   -!- CATALYTIC ACTIVITY: NTP + AMP = NDP + ADP. {ECO:0000255|HAMAP-
CC       Rule:MF_03170}.
CC   -!- CATALYTIC ACTIVITY: ATP + nucleoside diphosphate = ADP +
CC       nucleoside triphosphate. {ECO:0000255|HAMAP-Rule:MF_03170}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=5.3 uM for AMP with ATP as phosphate donor
CC         {ECO:0000269|PubMed:19766732};
CC         KM=1.4 uM for AMP with GTP as phosphate donor
CC         {ECO:0000269|PubMed:19766732};
CC         KM=507 uM for dAMP with ATP as phosphate donor
CC         {ECO:0000269|PubMed:19766732};
CC         Vmax=90 pmol/min/ug enzyme with AMP as substrate and ATP as
CC         phosphate donor {ECO:0000269|PubMed:19766732};
CC         Vmax=80 pmol/min/ug enzyme with AMP as substrate and GTP as
CC         phosphate donor {ECO:0000269|PubMed:19766732};
CC         Vmax=88 pmol/min/ug enzyme with dAMP as substrate and ATP as
CC         phosphate donor {ECO:0000269|PubMed:19766732};
CC   -!- SUBUNIT: Monomer. {ECO:0000255|HAMAP-Rule:MF_03170,
CC       ECO:0000269|Ref.13}.
CC   -!- SUBCELLULAR LOCATION: Mitochondrion matrix {ECO:0000255|HAMAP-
CC       Rule:MF_03170, ECO:0000269|PubMed:11485571,
CC       ECO:0000269|PubMed:19766732}.
CC   -!- TISSUE SPECIFICITY: Highly expressed in kidney, moderately
CC       expressed in heart and liver and weakly expressed in brain.
CC       {ECO:0000269|PubMed:11485571}.
CC   -!- DOMAIN: Consists of three domains, a large central CORE domain and
CC       two small peripheral domains, NMPbind and LID, which undergo
CC       movements during catalysis. The LID domain closes over the site of
CC       phosphoryl transfer upon GTP/ATP binding. Assembling and
CC       dissambling the active center during each catalytic cycle provides
CC       an effective means to prevent GTP/ATP hydrolysis.
CC       {ECO:0000255|HAMAP-Rule:MF_03170, ECO:0000305|PubMed:19073142}.
CC   -!- SIMILARITY: Belongs to the adenylate kinase family. AK3 subfamily.
CC       {ECO:0000255|HAMAP-Rule:MF_03170}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X60673; CAA43088.1; -; mRNA.
DR   EMBL; CR456830; CAG33111.1; -; mRNA.
DR   EMBL; AK313611; BAG36374.1; -; mRNA.
DR   EMBL; AL356212; CAI22412.1; -; Genomic_DNA.
DR   EMBL; AC099680; CAI22412.1; JOINED; Genomic_DNA.
DR   EMBL; CH471059; EAX06538.1; -; Genomic_DNA.
DR   EMBL; CH471059; EAX06540.1; -; Genomic_DNA.
DR   EMBL; CH471059; EAX06544.1; -; Genomic_DNA.
DR   EMBL; BC016180; AAH16180.1; -; mRNA.
DR   EMBL; BC040224; AAH40224.1; -; mRNA.
DR   EMBL; BC066944; AAH66944.1; -; mRNA.
DR   EMBL; BC136886; AAI36887.1; -; mRNA.
DR   EMBL; BC136887; AAI36888.1; -; mRNA.
DR   EMBL; BC148270; AAI48271.1; -; mRNA.
DR   EMBL; BC146653; AAI46654.1; -; mRNA.
DR   CCDS; CCDS629.1; -.
DR   PIR; A42820; KIHUA3.
DR   RefSeq; NP_001005353.1; NM_001005353.2.
DR   RefSeq; NP_037542.1; NM_013410.3.
DR   RefSeq; NP_982289.1; NM_203464.2.
DR   UniGene; Hs.10862; -.
DR   PDB; 2AR7; X-ray; 2.15 A; A/B=1-223.
DR   PDB; 2BBW; X-ray; 2.05 A; A/B=1-223.
DR   PDB; 3NDP; X-ray; 2.30 A; A/B=1-223.
DR   PDBsum; 2AR7; -.
DR   PDBsum; 2BBW; -.
DR   PDBsum; 3NDP; -.
DR   ProteinModelPortal; P27144; -.
DR   SMR; P27144; -.
DR   BioGrid; 106708; 12.
DR   IntAct; P27144; 4.
DR   STRING; 9606.ENSP00000322175; -.
DR   BindingDB; P27144; -.
DR   ChEMBL; CHEMBL4926; -.
DR   DrugBank; DB00718; Adefovir Dipivoxil.
DR   DrugBank; DB00300; Tenofovir.
DR   iPTMnet; P27144; -.
DR   PhosphoSitePlus; P27144; -.
DR   BioMuta; AK4; -.
DR   DMDM; 125157; -.
DR   UCD-2DPAGE; P27144; -.
DR   EPD; P27144; -.
DR   MaxQB; P27144; -.
DR   PaxDb; P27144; -.
DR   PeptideAtlas; P27144; -.
DR   PRIDE; P27144; -.
DR   TopDownProteomics; P27144; -.
DR   DNASU; 205; -.
DR   Ensembl; ENST00000327299; ENSP00000322175; ENSG00000162433.
DR   Ensembl; ENST00000395334; ENSP00000378743; ENSG00000162433.
DR   Ensembl; ENST00000545314; ENSP00000445912; ENSG00000162433.
DR   GeneID; 205; -.
DR   KEGG; hsa:205; -.
DR   UCSC; uc001dby.3; human.
DR   CTD; 205; -.
DR   DisGeNET; 205; -.
DR   GeneCards; AK4; -.
DR   HGNC; HGNC:363; AK4.
DR   HPA; HPA042753; -.
DR   HPA; HPA049461; -.
DR   MIM; 103030; gene.
DR   neXtProt; NX_P27144; -.
DR   OpenTargets; ENSG00000162433; -.
DR   PharmGKB; PA165750325; -.
DR   eggNOG; KOG3078; Eukaryota.
DR   eggNOG; COG0563; LUCA.
DR   GeneTree; ENSGT00550000074679; -.
DR   HOGENOM; HOG000238772; -.
DR   HOVERGEN; HBG000458; -.
DR   InParanoid; P27144; -.
DR   KO; K00939; -.
DR   OMA; CLLDGYP; -.
DR   OrthoDB; EOG091G06BH; -.
DR   PhylomeDB; P27144; -.
DR   TreeFam; TF312916; -.
DR   BRENDA; 2.7.4.3; 2681.
DR   Reactome; R-HSA-499943; Synthesis and interconversion of nucleotide di- and triphosphates.
DR   EvolutionaryTrace; P27144; -.
DR   GeneWiki; AK3L1; -.
DR   GenomeRNAi; 205; -.
DR   PRO; PR:P27144; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000162433; -.
DR   CleanEx; HS_AK3; -.
DR   CleanEx; HS_AK3L1; -.
DR   ExpressionAtlas; P27144; baseline and differential.
DR   Genevisible; P27144; HS.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0005759; C:mitochondrial matrix; ISS:BHF-UCL.
DR   GO; GO:0005739; C:mitochondrion; IDA:BHF-UCL.
DR   GO; GO:0004017; F:adenylate kinase activity; IDA:BHF-UCL.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0005525; F:GTP binding; IEA:UniProtKB-KW.
DR   GO; GO:0004550; F:nucleoside diphosphate kinase activity; IDA:UniProtKB.
DR   GO; GO:0050145; F:nucleoside phosphate kinase activity; TAS:Reactome.
DR   GO; GO:0046899; F:nucleoside triphosphate adenylate kinase activity; IDA:BHF-UCL.
DR   GO; GO:0046033; P:AMP metabolic process; IDA:BHF-UCL.
DR   GO; GO:0046034; P:ATP metabolic process; IDA:BHF-UCL.
DR   GO; GO:0007420; P:brain development; IEA:Ensembl.
DR   GO; GO:0046039; P:GTP metabolic process; IDA:BHF-UCL.
DR   GO; GO:0001889; P:liver development; IEA:Ensembl.
DR   GO; GO:0015949; P:nucleobase-containing small molecule interconversion; TAS:Reactome.
DR   GO; GO:0006165; P:nucleoside diphosphate phosphorylation; IDA:UniProtKB.
DR   GO; GO:0009142; P:nucleoside triphosphate biosynthetic process; IDA:UniProtKB.
DR   GO; GO:0042493; P:response to drug; IEA:Ensembl.
DR   CDD; cd01428; ADK; 1.
DR   HAMAP; MF_00235; Adenylate_kinase_Adk; 1.
DR   HAMAP; MF_03169; Adenylate_kinase_AK3; 1.
DR   HAMAP; MF_03170; Adenylate_kinase_AK4; 1.
DR   InterPro; IPR006259; Adenyl_kin_sub.
DR   InterPro; IPR000850; Adenylat/UMP-CMP_kin.
DR   InterPro; IPR033690; Adenylat_kinase_CS.
DR   InterPro; IPR007862; Adenylate_kinase_lid-dom.
DR   InterPro; IPR028586; AK3/Ak4_mitochondrial.
DR   InterPro; IPR028585; AK4_mitochondrial.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   PANTHER; PTHR23359; PTHR23359; 1.
DR   Pfam; PF05191; ADK_lid; 1.
DR   PRINTS; PR00094; ADENYLTKNASE.
DR   SUPFAM; SSF52540; SSF52540; 2.
DR   SUPFAM; SSF57774; SSF57774; 1.
DR   TIGRFAMs; TIGR01351; adk; 1.
DR   PROSITE; PS00113; ADENYLATE_KINASE; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; ATP-binding; Complete proteome;
KW   GTP-binding; Kinase; Mitochondrion; Nucleotide-binding;
KW   Reference proteome; Transferase.
FT   CHAIN         1    223       Adenylate kinase 4, mitochondrial.
FT                                /FTId=PRO_0000158926.
FT   NP_BIND      15     20       NTP. {ECO:0000255|HAMAP-Rule:MF_03170,
FT                                ECO:0000269|Ref.13}.
FT   NP_BIND      62     64       AMP. {ECO:0000255|HAMAP-Rule:MF_03170,
FT                                ECO:0000269|Ref.13}.
FT   NP_BIND      89     92       AMP. {ECO:0000255|HAMAP-Rule:MF_03170,
FT                                ECO:0000269|Ref.13}.
FT   NP_BIND     135    136       NTP. {ECO:0000255|HAMAP-Rule:MF_03170}.
FT   REGION       35     64       NMPbind. {ECO:0000255|HAMAP-
FT                                Rule:MF_03170,
FT                                ECO:0000269|PubMed:19073142}.
FT   REGION      125    162       LID. {ECO:0000255|HAMAP-Rule:MF_03170,
FT                                ECO:0000269|PubMed:19073142}.
FT   BINDING      36     36       AMP. {ECO:0000255|HAMAP-Rule:MF_03170,
FT                                ECO:0000269|Ref.13}.
FT   BINDING      41     41       AMP. {ECO:0000255|HAMAP-Rule:MF_03170}.
FT   BINDING      96     96       AMP. {ECO:0000255|HAMAP-Rule:MF_03170}.
FT   BINDING     126    126       NTP. {ECO:0000255|HAMAP-Rule:MF_03170,
FT                                ECO:0000269|Ref.13}.
FT   BINDING     170    170       AMP. {ECO:0000255|HAMAP-Rule:MF_03170,
FT                                ECO:0000269|Ref.13}.
FT   BINDING     199    199       NTP; via carbonyl oxygen.
FT                                {ECO:0000255|HAMAP-Rule:MF_03170,
FT                                ECO:0000269|Ref.13}.
FT   MOD_RES      60     60       N6-succinyllysine.
FT                                {ECO:0000250|UniProtKB:Q9WUR9}.
FT   MOD_RES     175    175       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:Q9WUR9}.
FT   MOD_RES     179    179       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q9WUR9}.
FT   MOD_RES     179    179       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q9WUR9}.
FT   MOD_RES     186    186       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q9WUR9}.
FT   MOD_RES     186    186       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q9WUR9}.
FT   MUTAGEN       4      4       K->G: Abolishes mitochondrial import;
FT                                when associated with G-7.
FT                                {ECO:0000269|PubMed:19766732}.
FT   MUTAGEN       7      7       R->G: Abolishes mitochondrial import;
FT                                when associated with G-4.
FT                                {ECO:0000269|PubMed:19766732}.
FT   CONFLICT     22     22       C -> S (in Ref. 6; AAH40224/AAI46654).
FT                                {ECO:0000305}.
FT   CONFLICT     23     23       Q -> R (in Ref. 6; AAH66944).
FT                                {ECO:0000305}.
FT   STRAND        7     11       {ECO:0000244|PDB:2BBW}.
FT   HELIX        18     29       {ECO:0000244|PDB:2BBW}.
FT   STRAND       32     34       {ECO:0000244|PDB:2AR7}.
FT   HELIX        36     45       {ECO:0000244|PDB:2BBW}.
FT   HELIX        49     59       {ECO:0000244|PDB:2BBW}.
FT   HELIX        66     78       {ECO:0000244|PDB:2BBW}.
FT   TURN         79     82       {ECO:0000244|PDB:2AR7}.
FT   STRAND       85     89       {ECO:0000244|PDB:2BBW}.
FT   HELIX        94    101       {ECO:0000244|PDB:2BBW}.
FT   STRAND      108    113       {ECO:0000244|PDB:2BBW}.
FT   HELIX       116    124       {ECO:0000244|PDB:2BBW}.
FT   STRAND      126    129       {ECO:0000244|PDB:2BBW}.
FT   TURN        130    133       {ECO:0000244|PDB:2BBW}.
FT   STRAND      134    137       {ECO:0000244|PDB:2BBW}.
FT   TURN        138    140       {ECO:0000244|PDB:2BBW}.
FT   TURN        150    152       {ECO:0000244|PDB:2BBW}.
FT   HELIX       160    162       {ECO:0000244|PDB:2BBW}.
FT   HELIX       164    187       {ECO:0000244|PDB:2BBW}.
FT   STRAND      191    195       {ECO:0000244|PDB:2BBW}.
FT   HELIX       199    211       {ECO:0000244|PDB:2BBW}.
FT   HELIX       217    219       {ECO:0000244|PDB:3NDP}.
FT   HELIX       220    222       {ECO:0000244|PDB:2BBW}.
SQ   SEQUENCE   223 AA;  25268 MW;  653341A8EB3BC723 CRC64;
     MASKLLRAVI LGPPGSGKGT VCQRIAQNFG LQHLSSGHFL RENIKASTEV GEMAKQYIEK
     SLLVPDHVIT RLMMSELENR RGQHWLLDGF PRTLGQAEAL DKICEVDLVI SLNIPFETLK
     DRLSRRWIHP PSGRVYNLDF NPPHVHGIDD VTGEPLVQQE DDKPEAVAAR LRQYKDVAKP
     VIELYKSRGV LHQFSGTETN KIWPYVYTLF SNKITPIQSK EAY
//
